Global 3D cell culture market valued at $1.18B in 2024, $1.29B in 2025, and set to hit $2.26B by 2030, growing at 11.7% CAGR. 3D cell culture technologies represent a paradigm shift in biomedical ...

3D cell models offer a more physiologically relevant environment than traditional 2D cultures, making them a preferred option for modern drug discovery workflows. However, adapting high-throughput ...

This webinar is hosted by Thermo Fisher Scientific in collaboration with the Walter and Eliza Hall Institute of Medical Research (WEHI). The webinar will aim to provide an overview of recombinant ...

Officials at India-based Syngene International, a CRDMO, report that the company executed site upgrades to accelerate drug discovery and development. The investments included a dedicated peptide ...